TL;DR
- •Benzodiazepines act on GABA receptors and produce fast anxiety relief within 30–60 minutes.
- •Long-term use causes tolerance (rising dose for same effect) and physical dependence (withdrawal symptoms with missed doses).
- •Withdrawal from chronic benzodiazepine use can be dangerous — never stop abruptly; always physician-supervised taper.
- •First-line long-term anxiety alternatives are SSRIs/SNRIs (slow onset, no tolerance), buspirone (non-sedating), and CBT.
- •Ketamine works through glutamate signaling rather than GABA — different mechanism, doesn't carry the same tolerance/dependence profile.
- •Ketamine treatment can run alongside a physician-guided benzodiazepine taper; it doesn't replace the taper but can reduce the underlying anxiety driving daily use.
How this class works
Benzodiazepines enhance the effect of GABA, the brain's primary inhibitory neurotransmitter. The result is fast, reliable sedation, anxiolysis, and muscle relaxation — typically within 30-60 minutes. The same mechanism makes them tolerance-forming and physiologically dependence-producing with regular use. Long-term cognitive effects, fall risk in older adults, and dangerous interactions with alcohol and opioids have made the prescribing community more cautious over the past decade.
Medications in this class
Tovani has detailed drug-interaction pages for 2 benzodiazepines. Click any to see the ketamine-interaction verdict, mechanism, and FAQ.
Why patients look for alternatives
- •Concern about tolerance — needing higher doses for the same effect
- •Physical dependence — withdrawal symptoms when doses are missed or reduced
- •Cognitive side effects (memory, attention, "fogginess")
- •Doctor recommending a taper for safety reasons
- •Sedation or fatigue interfering with daily function
- •Wanting a long-term solution rather than acute symptom management
Where ketamine fits
Clinical indication
Treatment-resistant anxiety, panic disorder, and PTSD — particularly when benzodiazepines have been used long-term and the patient or physician wants a different mechanism. Ketamine targets glutamate signaling rather than GABA, so it doesn't carry the same tolerance/dependence profile and works through a fundamentally different brain pathway.
Onset comparison
Hours of measurable anxiolysis vs benzodiazepines' 30-60 minutes — but ketamine's effect comes from underlying neural changes rather than acute receptor occupancy, so the benefit persists between sessions without daily dosing.
Contraindications and coordination
If you're currently on a daily benzodiazepine, do not stop or reduce abruptly — benzodiazepine withdrawal can be dangerous. Ketamine treatment can proceed alongside a slow physician-guided taper. Active substance use disorder, uncontrolled hypertension, severe cardiovascular disease, and active psychotic disorder are general contraindications.
5-minute screening · Reviewed by a board-certified physician · FL & NJ
Other alternatives worth knowing about
Ketamine isn’t the only escalation path. These are the other options your physician may consider, depending on your history.
SSRIs / SNRIs for anxiety
First-line long-term treatment for generalized anxiety disorder and panic disorder. Slower to take effect (4-8 weeks) but no tolerance or physical dependence.
Buspirone (Buspar)
Non-sedating, non-dependence-forming anxiolytic. Works for generalized anxiety but not acute panic. Takes 2-4 weeks for full effect.
Beta-blockers (off-label)
Propranolol for performance anxiety and physical anxiety symptoms (palpitations, tremor). Doesn't address cognitive worry but blocks the autonomic response.
CBT, particularly exposure-based therapy for panic
Strong evidence base for panic disorder and specific phobias. Often combined with one of the above medication strategies.
Frequently asked
Can I take ketamine while still on a benzodiazepine?
In most cases, yes — but the interaction needs physician oversight. Both medications are CNS depressants and the combination can cause more sedation than either alone. Your physician will review your full benzodiazepine history (drug, dose, duration of use) and may recommend a dose adjustment around session days. Do not stop your benzodiazepine on your own — abrupt discontinuation can be dangerous.
Will ketamine help me get off benzodiazepines?
Ketamine isn't a benzodiazepine taper drug specifically, but it can be a valuable part of a comprehensive plan when you're working toward reducing or discontinuing chronic benzodiazepine use. By addressing the underlying anxiety, panic, or PTSD that originally drove benzodiazepine use, ketamine therapy can reduce the perceived "need" for daily dosing, which makes a physician-guided taper more achievable.
I've tried multiple SSRIs and they didn't help my anxiety. Is ketamine an option?
Yes — ketamine works through a completely different mechanism (glutamate/NMDA) than SSRIs (serotonin), so patients who haven't responded to multiple SSRIs often do respond to ketamine. About 60-70% of patients with treatment-resistant anxiety or depression show measurable response to ketamine within hours of the first session.
Is at-home ketamine safer than benzodiazepines for anxiety?
"Safer" depends on the specific risk profile that matters to you. Benzodiazepines have well-known dependence and tolerance risks with long-term use, plus dangerous interactions with alcohol and opioids. Sublingual ketamine doesn't carry the same dependence profile when used at therapeutic doses under physician supervision. Both medications have safety considerations and require medical screening; the right comparison is best made with your physician based on your specific history.
How long does ketamine take to work for anxiety compared to a benzodiazepine?
A benzodiazepine like Xanax produces measurable anxiety reduction within 30-60 minutes via direct GABA receptor activation. Ketamine's effect on anxiety is measurable within hours of the first session and is thought to come from underlying changes in glutamate signaling and neural connectivity. So the immediate onset is slower than a benzo, but the benefit persists between sessions without daily dosing — which is the opposite trade-off from benzodiazepines.
References
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine produced 64% response in treatment-resistant depression with comorbid anxiety vs 28% placebo. PMID 23982301
- Sanacora G et al. 2017, JAMA Psychiatry. APA consensus on ketamine's safety and rapid effects in complex psychiatric presentations including anxiety-spectrum disorders. PMID 28249076